mjzanon - Brazil IP counsel for foreign law firms, agents and in-house teams. - Page 154

BlueWillow Biologics announces issuance of intranasal Anthrax Vaccine patent

Wednesday, May 29, 2019 DrugName : anthrax vaccine BlueWillow Biologics announced the issuance of U.S. patent number 10,138,279 covering an

European Medicines Agency (EMA) Accepts Marketing Authorisation Application for Prestige BioPharma’s Trastuzumab Biosimilar HD201 for Review

Tuesday, May 28, 2019 | DrugName : trastuzumab biosimilar Prestige BioPharma (herein, Prestige) announced that European Medicines Agency (EMA) has

Zebra Medical receives FDA clearance for AI chest X-ray product

Tuesday, May 14, 2019 DrugName : HealthPNX Israeli company Zebra Medical Vision has secured 510(k) clearance from the US Food

University of California awarded CRISPR-Cas9-related patent for techniques that regulate gene expressionHeading

Tuesday, May 28, 2019 The U.S. Patent and Trademark Office has issued a new patent to University of California (UC),

Health Canada approves Biocon and Mylan’s Ogivri, the first Trastuzumab Biosimilar, for the treatment of HER2-positive Breast and Gastric Cancers

Wednesday, May 22, 2019 | DrugName : trastuzumab biosimilar [sg_popup id=”2993″ event=”inherit”][/sg_popup]Biocon Ltd. and Mylan N.V. announced that Health Canada

Brazil IP counsel for foreign law firms, agents and in-house teams.